A shared passion to make longevity accessible
For the billions - not just the billionaires
Scientific Board
Dr. Michael Sagner, MD
Dr. Sagner is a world leading human performance specialist, sports and preventive medicine, and was the medical director at Europe’s first University medical center section for preventive medicine and lifestyle medicine. Dr Sagner is a member of the European Union Platform for Action on Diet, Physical Activity and Health and a partner of the European Innovation Partnership on Active and Healthy Aging.
Dr. Sagner, a clinician, has led endocrinology and cardiometabolic interventions like GLP1 agonists in Europe. As editor-in-chief of Progress in Preventive Medicine, he champions P4 medicine—predictive, preventive, personalized, participatory—and systems biology-based prevention.
Combining systems biology and consumer-driven healthcare, he advocates for a shift from reactive to P4 medicine, making disease care more cost-effective and personalized. As a public health expert, he initiates global projects, collaborating with entities like WHF, the World Obesity Federation, and the WHO. He bridges clinical practice and public health for more patient-centric care and preventive interventions, promoting a 'cell to community' approach.
He then co-founded a private clinic group and research institute for cardiology, metabolism, endocrinology, preventive medicine and sports medicine where he looks after elite athletes, VIPs and executives.
Francois-Xavier Pellay, PhD
Francois-Xavier Pellay, PhD, known as the 'Longevity Molecule Hunter', is a world leading scientist and entrepreneur in the longevity industry. Pellay is a multidisciplinary scientist with a background which includes a Master's degree in Biochemistry, a Master's degree in Organic Chemistry, a Ph.D. in Bioinformatics and years of expertise in Microbiology, Molecular Biology, Cellular Biology and Biology of Aging.
Pellay spent 11 years in skin rejuvenation cosmetics research, heading aging and longevity research at NAOS group and leading the longevity group at Medils for 7 years. His work led to the discovery of longevity molecules now used in cosmetics and explored for neurodegenerative diseases. In the last 3 years, Pellay founded breakthrough longevity companies, including Cell Culture Lab for skin rejuvenation, and Bimini Biotech and Santogenesis focused on discovering longevity drugs for age-related diseases.
Avi Roy, PhD
Dr. Avi Roy is an accomplished biomedical scientist, mentor, and entrepreneur with a deep-rooted passion for advancing the field of longevity. His academic journey culminated in a PhD from the University of Oxford. With over 15 years of dedicated research and development in the longevity sector, Dr. Roy has established himself as a a leading figure in this dynamic and ever-evolving field. As a mentor and investor in health-tech startups, he continues to inspire and guide the next generation of scientists and entrepreneurs.
Beyond his academic achievements, Dr. Roy has served as a Visiting Researcher at the Centre for Advancing Sustainable Medical Innovations, both at the University of Oxford and University College London. He has held roles as President of the Biogerontology Research Foundation (BGRF) and as the Chief Technology Officer at BioViva USA Inc. Dr. Roy's commitment to disseminating knowledge in his field led him to found the Big Data Science in Medicine Conference and The Longevity Reporter. He is also recognized for his varied writings in The Conversation and The Guardian.
Dr. Fady Hannah-Shmouni
Dr. Fady Hannah-Shmouni, MD FRCPC, is a physician-investor at the forefront of endocrinology, genomics, and healthspan medicine. As a distinguished Professor at the University of British Columbia, he passionately empowers individuals by facilitating access to groundbreaking technologies in precision medicine, including artificial intelligence and genomic advancements.
Beyond his academic contributions, Dr. Hannah-Shmouni serves as the Managing Partner of FHS Capital, an innovative early-stage investment fund that has successfully nurtured a diverse portfolio of companies across various sectors, including consumer health products. He is also the founder of Healthspan Digital, headquartered in Abu Dhabi, where he is scaling healthspan services through state-of-the-art AI solutions and smart home technologies. With an unwavering commitment to fostering innovation and enhancing healthcare accessibility, Dr. Hannah-Shmouni is dedicated to optimizing how individuals manage their health and well-being, paving the way for a healthier future for all.
Explore our products
Products are engineered to work in synergy - get 15% off your monthly longevity kit when you combine Longevity Foundation with any booster.
-
SLEEP
Advanced Sleep Repair
Our Fasting Tonic™ doesn't stop at curbing hunger; it goes a step further by replenishing essential micronutrients and electrolytes
Learn More -
FOUNDATION
Longevity Foundation
Our baseline, flagship product, the Longevity Essentials formula targets all 12 underlying causes of aging, on the smallest, subcellular
Learn More -
GLUCOSE
Glucose Blocker
Our Fasting Tonic™ doesn't stop at curbing hunger; it goes a step further by replenishing essential micronutrients and electrolytes that
Learn More
Learn About Longevity
With everything from breaking science to actionable advice and strategies, our library is your oracle for knowledge to optimize health, and performance and give you more control over your health span.
